These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5701513)

  • 1. [Chromotropic, inotropic and coronary dilator actions of some heptaminol derivatives].
    Duchêne-Marullaz P; Cosnier D; Szabo S; Mollat F
    Therapie; 1968; 23(2):383-97. PubMed ID: 5701513
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coronary dilator effect of theophylline-heptaminol acetate and cinnarizine in the anesthetized dog].
    Loubatieres A; Bouyard P; Klein M; Alric R
    Therapie; 1965; 20(3):809-13. PubMed ID: 4378819
    [No Abstract]   [Full Text] [Related]  

  • 3. [Various aspects of the pharmacology of iproveratril, a new synthetic coronary dilator with anti-arrhythmic value].
    Melville KI; Shister HE; Mignault Jde L; Garvey L
    Union Med Can; 1969 Apr; 98(4):592-6. PubMed ID: 5355792
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacologic viewpoint on so-called coronary dilator drugs].
    Faucon G; Evreux JC; Bazaugour R
    Therapie; 1970; 25(2):275-92. PubMed ID: 5526209
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phenylbutylamino derivatives with a stimulating effect on the adrenergic beta-receptors and their action on the coronary circulation of dogs].
    Becker KH; Boltze KH; Lorenz D; Oberdörster G
    Arzneimittelforschung; 1966 Jul; 16(7):833-5. PubMed ID: 6014711
    [No Abstract]   [Full Text] [Related]  

  • 6. [The mechanism of coronary dilatating action of nifedipine].
    Kosche F; Raff WK; Lochner W
    Arzneimittelforschung; 1972 Jan; 22(1):39-42. PubMed ID: 5066996
    [No Abstract]   [Full Text] [Related]  

  • 7. [Coronary dilating properties of dihydroxyquinolenes with a xanthine substitution].
    Mercier J; Dessaigne S; Lespagnol A
    C R Seances Soc Biol Fil; 1973; 167(1):90-2. PubMed ID: 4804706
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of hexobendine on the arterial and coronary venous CO2 tension and hydrogen-ion concentration in dogs. Contribution on the theory of the mechanism of action of coronary dilator agents].
    Kraupp O; Grossmann W; Stühlinger W; Raberger G
    Arzneimittelforschung; 1968 Aug; 18(8):1067-73. PubMed ID: 5755840
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of flavon-7-ethyl oxyacetate on the cardiovascular system].
    Takenaka F; Takeya N; Tazume Y; Hayakawa T; Sakai M
    Kumamoto Igakkai Zasshi; 1967 Sep; 41(9):843-8. PubMed ID: 5631463
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of Intensain, a coronary dilator, on hemodynamics and its application for general anesthesia].
    Saito T; Okazaki K; Hirano T; Matsuzaki T; Wakizaka K
    Masui; 1966 Mar; 15(3):251-7. PubMed ID: 6007412
    [No Abstract]   [Full Text] [Related]  

  • 11. [Enhancement of the coronary dilator action of i.v. and i.c. administered adenosine following intraduodenal provision of hexobendine in dogs].
    Raberger G; Kraupp O
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):430-1. PubMed ID: 4254341
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of cardiovascular actions of CS-611, a new coronary dilator, in the dog.
    Motomura S; Satoh K; Yamashita S; Taira N
    Arzneimittelforschung; 1981; 31(8):1238-44. PubMed ID: 7197528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of diphenylalkyl derivatives. I. Comparative studies of coronary dilator diphenylalkylamine derivatives.
    Leszkovszky G; Tardos L; Erdély I; Harsányi K
    Acta Physiol Acad Sci Hung; 1966; 29(3):283-97. PubMed ID: 5923039
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
    Raff WK; Kosche F; Lochner W
    Arzneimittelforschung; 1972 Jan; 22(1):33-9. PubMed ID: 5066995
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influencing of oxygen pressure in the myocardium by coronary dilators].
    Kadatz R; Diederen W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):156-9. PubMed ID: 5804228
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular responses to intracoronary infusion of prostaglandin E-1, F-1 alpha and F-2 alpha.
    Hollenberg M; Walker RS; McCormick DP
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):66-73. PubMed ID: 5684294
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the effect of various halothane concentrations on coronary blood flow].
    Dudziak R
    Anaesthesist; 1966 May; 15(5):155-7. PubMed ID: 5987180
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary pharmacological studies on some benzofuran derivatives with coronary dilating action].
    Pisanti N; Volterra G
    Farmaco Sci; 1971 Apr; 26(4):312-21. PubMed ID: 5559991
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sympatholytic ("antisympathotonic") substances].
    Kruger K
    Minerva Med; 1968 Dec; 59(96):5227-30. PubMed ID: 5710726
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of some new nor-camphane derivatives on the coronary flow.
    Sen P; Kapoor SL; Sanyal RK
    Indian J Physiol Pharmacol; 1969 Jul; 13(3):123-30. PubMed ID: 5362626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.